Stay updated on IBI310 and Siltilimab in NPC Clinical Trial

Sign up to get notified when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBI310 and Siltilimab in NPC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T21:15:46.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    6%
    Check dated 2025-02-10T10:22:22.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T08:59:10.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T23:39:23.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.
    Difference
    1.0%
    Check dated 2025-01-12T18:44:19.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:49:26.000Z thumbnail image

Stay in the know with updates to IBI310 and Siltilimab in NPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.